Stock Ratings / Health Care / TEVA / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Teva Pharmaceutical Industries Limited (TEVA) 12-Month Stock Forecast & Price Target Cone

$41.47 +3.75% NYSE • Public Delayed / 60s Snapshot

Teva Pharmaceutical Industries Limited (TEVA) receives a Roarable Rating of D+ (Sell) and flashes a Red SELL / AVOID warning (61/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+153.8% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.

ROARABLE D+ • SELL / AVOID Cap $48.32B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE+1.4% Base Target

WHALE OPTIONS TUG-OF-WAR:64% Call Buyers ($5.6M)

36% PutsMax Pain: $41.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your TEVA Position Size: $10,000

Shares at $41.47: 241.1 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $32.78

$7,905

$-2,095 (-21.0%)

12M Consensus BaseTarget $42.03

$10,135

+$135 (+1.4%)

12M Bull Case BreakoutTarget $49.60

$11,960

+$1,960 (+19.6%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$44	74%	A
Goldman SachsSector Coverage Lead	BUY	$47	69%	B
JP MorganUS Large-Cap Research	HOLD	$37	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk

Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring TEVA)

✓Live walkthrough of TEVA's RQD Radar, SEC cash-conversion gap & downside levels
✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
✓Includes instant 24/7 email alert whenever any of your stocks flip to Red

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

TEVA // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +20.02%📐 HORIZONTAL RANGE

2026-10-30O $41.17H $42.59L $41.17C $42.09VOL 7.36M

RES: $43.46SUP: $23.90SMA50: $39.08SMA200: $34.58

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

TEVA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 TEVA Butterfly Map → + Track TEVA →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

26.5%/yr Implied 5Y Growth

vs. +4.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on TEVA today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for TEVA. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for TEVA today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

TEVA Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is TEVA's 12-month stock price target?

Teva Pharmaceutical Industries Limited (TEVA) carries a 12-month consensus base price target of $42.03 (+1.4% from $41.47), with a bull-case target of $49.6 and a bear-case floor of $32.78.

Is TEVA stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates TEVA D+ (Sell — SELL) with an RQD Confidence score of 61/100.

Direct Sub-Reports: TEVA RQD Cockpit TEVA 12M Forecast TEVA Earnings & Move TEVA Dividends & DRIP TEVA Insiders & 13F TEVA Whale Options TEVA Profit Sankey TEVA News & Why